Respiratory Therapy Solutions Available to Intalere Members through New Agreement with Vapotherm
St. Louis (February 22, 2021) – Intalere, the healthcare industry leader in delivering solutions designed for improved financial, operational and clinical health for our partners, announces a new agreement for respiratory therapy products from Vapotherm, Inc.
Through this agreement, Intalere members will receive negotiated pricing on Vapotherm’s Precision Flow Plus to deliver high velocity therapy, a mask-free alternative to non-invasive ventilation for patients in respiratory distress. The Precision Flow Plus was designed with ease of use in mind. Control flow, oxygen and temperature independently with the push of a single button.
This contract is currently effective through December 31, 2022.
About Vapotherm, Inc.
Vapotherm, Inc. (NYSE: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 2.5 million patients have been treated with the use of Vapotherm high velocity therapy® systems. For more information, visit www.vapotherm.com.
Intalere’s mission focuses on elevating the health of healthcare by designing solutions to improve our members’ financial, operational and clinical performance. We empower our customers and deliver measurable results through our highly personalized approach of creating strategies and programs focused on their goals. From managing their entire spend to strategic consulting around diagnosing particular areas of concern, our unique provider led model allows us to leverage nationally recognized best practices in supply chain and patient outcomes to drive efficiencies for our members. To learn more, visit www.intalere.com.